,address1,address2,city,state,zip,country,phone,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,exDividendDate,payoutRatio,beta,trailingPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,630 Fifth Avenue,Suite 2260,New York,NY,10020,United States,650 812 8700,https://www.affymax.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.",2,"{'maxAge': 1, 'name': 'Mr. Mark G. Thompson', 'age': 60, 'title': 'CFO & Sec.', 'yearBorn': 1962, 'fiscalYear': 2013, 'totalPay': 97488, 'exercisedValue': 0, 'unexercisedValue': 0}",1388448000,86400,4,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,1417132800,0.0,5.731673,Infinity,20,20,1221,1311,1311,0.0,0.0,0,0,2614932,0.0002,0.04,62.260284,0.00429,0.005902,0.0,0.0,USD,-3241541,73.0,37490100,18481851,15826827,1365984000,1368576000,0.493,0.0,1.0000001e-05,2.35,0.4935,622603008,0.138,0.030434782,1388448000,1419984000,1404086400,-0.531,3066000,0.0,-77.18,0.068,-0.32258064,0.14113986,0.05,1417132800,PNK,EQUITY,AFFY,AFFY,AFFYMAX INC,"Affymax, Inc.",1166193000,America/New_York,EDT,254a7d2b-7cbf-3019-b996-0863e9300106,finmb_1029032,-14400000,0.0042,none,3399000,0.091,-47648000,0,15.883,20.813,42000,0.001,-2.28909,1.1159201,-10488000,-41412124,-8366000,-0.537,-0.92,4.97619,0.0,-1146.5952,USD,
1,630 Fifth Avenue,Suite 2260,New York,NY,10020,United States,650 812 8700,https://www.affymax.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.",2,"{'maxAge': 1, 'name': 'Mr. Jonathan M. Couchman', 'age': 52, 'title': 'CEO, Pres & Director', 'yearBorn': 1970, 'exercisedValue': 0, 'unexercisedValue': 0}",1388448000,86400,4,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,1417132800,0.0,5.731673,Infinity,20,20,1221,1311,1311,0.0,0.0,0,0,2614932,0.0002,0.04,62.260284,0.00429,0.005902,0.0,0.0,USD,-3241541,73.0,37490100,18481851,15826827,1365984000,1368576000,0.493,0.0,1.0000001e-05,2.35,0.4935,622603008,0.138,0.030434782,1388448000,1419984000,1404086400,-0.531,3066000,0.0,-77.18,0.068,-0.32258064,0.14113986,0.05,1417132800,PNK,EQUITY,AFFY,AFFY,AFFYMAX INC,"Affymax, Inc.",1166193000,America/New_York,EDT,254a7d2b-7cbf-3019-b996-0863e9300106,finmb_1029032,-14400000,0.0042,none,3399000,0.091,-47648000,0,15.883,20.813,42000,0.001,-2.28909,1.1159201,-10488000,-41412124,-8366000,-0.537,-0.92,4.97619,0.0,-1146.5952,USD,
2,630 Fifth Avenue,Suite 2260,New York,NY,10020,United States,650 812 8700,https://www.affymax.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.",2,"{'maxAge': 1, 'name': 'Dr. Tracy J. Dunn Ph.D., J.D.', 'age': 59, 'title': 'VP of Intellectual Property & Legal Affairs', 'yearBorn': 1963, 'exercisedValue': 0, 'unexercisedValue': 0}",1388448000,86400,4,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,0.0042,1417132800,0.0,5.731673,Infinity,20,20,1221,1311,1311,0.0,0.0,0,0,2614932,0.0002,0.04,62.260284,0.00429,0.005902,0.0,0.0,USD,-3241541,73.0,37490100,18481851,15826827,1365984000,1368576000,0.493,0.0,1.0000001e-05,2.35,0.4935,622603008,0.138,0.030434782,1388448000,1419984000,1404086400,-0.531,3066000,0.0,-77.18,0.068,-0.32258064,0.14113986,0.05,1417132800,PNK,EQUITY,AFFY,AFFY,AFFYMAX INC,"Affymax, Inc.",1166193000,America/New_York,EDT,254a7d2b-7cbf-3019-b996-0863e9300106,finmb_1029032,-14400000,0.0042,none,3399000,0.091,-47648000,0,15.883,20.813,42000,0.001,-2.28909,1.1159201,-10488000,-41412124,-8366000,-0.537,-0.92,4.97619,0.0,-1146.5952,USD,
